Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Department of Veterans Affairs |
---|---|
Information provided by: | Department of Veterans Affairs |
ClinicalTrials.gov Identifier: | NCT00012610 |
Telepsychiatry is a novel means of providing expert psychiatric treatment to patients who live far from a source of care. If it can be demonstrated that treatment via telepsychiatry is as effective as in-person treatment, then many individuals with psychiatric illness will have easy access to psychiatric care, even if they live in geographically remote areas.
Condition | Intervention |
---|---|
Depression |
Procedure: Telepsychiatry |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Efficacy of Telepsychiatry in the Treatment of Depression |
Estimated Enrollment: | 119 |
Study Completion Date: | September 2000 |
Arms | Assigned Interventions |
---|---|
1 | Procedure: Telepsychiatry |
Background:
Telepsychiatry is a novel means of providing expert psychiatric treatment to patients who live far from a source of care. If it can be demonstrated that treatment via telepsychiatry is as effective as in-person treatment, then many individuals with psychiatric illness will have easy access to psychiatric care, even if they live in geographically remote areas.
Objectives:
The major goal of this study was to determine whether treatment of depressive disorders via telepsychiatry is as effective as in-person treatment. In addition, this study was designed to determine if depressed patients are as compliant and as satisfied with telepsychiatry as with in-person treatment.
Another goal was to compare the cost and cost-effectiveness of remote treatment via telepsychiatry to in-person treatment.
Methods:
In this randomized controlled trial, veterans who presented with depression to any of three VA Maryland Health Care facilities with a SCID-IV depression diagnosis and a Hamilton Rating Scale for Depression (Ham-D) score of 16 or above were eligible for participation. Eligible veterans were randomized to either "in-person" treatment or "remote" treatment. Treatment occurred over six months and consisted of psychotropic medication and psycho-education concerning the disease, medications, and side effects. The major outcome variables included changes in Ham-D depression ratings and Beck Depression Inventory (BDI) self-reported depression ratings.
Status:
Completed.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Depression, Hamilton 16 or above, SCID-IV depression diagnosis
Exclusion Criteria:
Responsible Party: | Department of Veterans Affairs ( Ruskin, Paul - Principal Investigator ) |
Study ID Numbers: | ACC 97-034 |
Study First Received: | March 14, 2001 |
Last Updated: | October 31, 2008 |
ClinicalTrials.gov Identifier: | NCT00012610 History of Changes |
Health Authority: | United States: Federal Government |
Depression Mental Disorders Mood Disorders Depressive Disorder Behavioral Symptoms |
Depression Mental Disorders Mood Disorders Depressive Disorder Behavioral Symptoms |